Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates
Condition(s):Neonatal ThrombocytopeniaLast Updated:January 27, 2021Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Neonatal ThrombocytopeniaLast Updated:January 27, 2021Active, not recruiting
Condition(s):Chemotherapy-induced ThrombocytopeniaLast Updated:April 1, 2021Recruiting
Condition(s):Thrombocytopenia; Inherited Platelet DisorderLast Updated:July 21, 2020Enrolling by invitation
Condition(s):Thrombocytopenia; Primary Thrombocytopenia,Unspecified; Thrombocytopenia Chemotherapy InducedLast Updated:October 18, 2017Terminated
Condition(s):Heparin-induced Thrombocytopenia (HIT)Last Updated:June 30, 2016Completed
Condition(s):Thrombocytopenia; Cytarabine Causing Adverse Effects in Therapeutic Use; LymphomaLast Updated:March 15, 2021Not yet recruiting
Condition(s):ThrombocytopeniaLast Updated:November 4, 2020Recruiting
Condition(s):Immune Thrombocytopenia; PregnancyLast Updated:October 19, 2017Unknown status
Condition(s):Thrombocytopenia; CirrhosisLast Updated:March 3, 2021Recruiting
Condition(s):ThrombocytopeniaLast Updated:December 14, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.